baber/WOPTO huggingface dataset:
Patent AU-2017279652-B2 (AU)
Title: Homomorphic Passcode Encryption
Inventor: QUIGLEY OLIVER S C
IPC: G06Q20/32
Filed: 2017-12-20
Granted: 2019-05-09
Abstract: Abstract A method of encrypting a passcode is disclosed. In one embodiment, the method includes: receiving an indication of a portion of the passcode; calculating a plaintext value based at least in part on the indication, wherein the plaintext value represents an encoded portion of the passcode; encrypting the plaintext value into ciphertext using a homomorphic encryption system; and updating a cumulative encryption string by executing a cumulative operation to aggregate the ciphertext corresponding to the encoded portion into the cumulative encryption string computed for a previous portion of the passcode, wherein the cumulative operation is dictated by a homomorphic property of the homomorphic encryption system.
Patent AU-2017290805-B2 (AU)
Title: Elimination of proliferating cells from stem cell-derived grafts
Inventor: KRAUSE KARL-HEINZ
IPC: A61K48/00
Filed: 2017-06-30
Granted: 2023-11-16
Abstract: Provided herein are methods and compositions for a suicide gene approach comprising an expression vector comprising a cell cycle-dependent promoter driving the expression of a suicide gene. Also provided herein are methods to render proliferative cells sensitive to a prodrug after transplantation but avoids expression of the suicide gene in post-mitotic cells, such as neurons.
Patent AU-2017292929-B2 (AU)
Title: Implants using ultrasonic backscatter for detecting electrophysiological signals
Inventor: MAHARBIZ MICHEL M
IPC: A61B5/00
Filed: 2017-07-07
Granted: 2022-11-24
Abstract: Described herein are implantable devices configured to detect an electrophysiological signal. Certain exemplary implantable devices comprise a first electrode and a second electrode configured to engage a tissue and detect an electrophysiological signal; an integrated circuit comprising a multi-transistor circuit and a modulation circuit configured to modulate a current based on the electrophysiological signal; and an ultrasonic transducer configured to emit an ultrasonic backscatter encoding the electrophysiological signal from the tissue based on the modulated current. Also described herein are systems that include one or more implantable devices and an interrogator comprising one or more ultrasonic transducers configured to transit ultrasonic waves to the one or more implantable devices or receive ultrasonic backscatter from the one or more implantable devices. Further described are computer systems for operating one or more implantable devices, and methods of detecting an electrophysiological signal in a tissue.
Patent AU-2017293847-B2 (AU)
Title: Apparatus and methods for heating water with refrigerant and phase change material
Inventor: TRANT TROY E
IPC: F24D17/02
Filed: 2017-07-06
Granted: 2023-02-23
Abstract: An apparatus for heating water has a tank for storing water and an air conditioning system that defines a refrigerant flow path through which refrigerant flows. The refrigerant flow path passes through a heat exchanger so that refrigerant heat is contributed to the tank. The heat exchanger houses a phase change material. A controller controls operation of the water heating apparatus.
Patent AU-2017302136-B2 (AU)
Title: Stable hydrolysis-resistant synthetic polyribosylribitolphosphate derivatives as vaccines against haemophilus influenzae type b
Inventor: SEEBERGER PETER H
IPC: C07H15/04
Filed: 2017-07-28
Granted: 2021-05-27
Abstract: The present invention provides a stable synthetic saccharide of Hib polyribosylribitol- phosphate (PRP) derivative and conjugate thereof. Said saccharide, said conjugate and pharmaceutical compositions thereof are hydrolysis-resistant, long-term stable and useful for the prevention and/or treatment of diseases associated with Haemophilus influenzae, and more specifically of diseases associated with Haemophilus influenzae type b, preferably diseases selected from meningitis, pneumonia, and epiglotitis. They have general formula (I): wherein A is formula (II) or formula (III); B is formula (IV); C is formula (V); D is formula (VI); E is formula (VII); F is formula (VIII) or formula (IX).
Patent AU-2017313420-B2 (AU)
Title: Diacylglycerol acyltransferase 2 inhibitors
Inventor: BOEHM MARKUS
IPC: A61K31/506
Filed: 2017-08-09
Granted: 2020-12-24
Abstract: Compounds of Formula (I) that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
Patent AU-2017320582-B2 (AU)
Title: Targeting ligands
Inventor: LI ZHEN
IPC: A61K31/713
Filed: 2017-03-07
Granted: 2023-11-16
Abstract: Described are novel targeting ligands that may be linked to compounds, such therapeutic compounds that are useful in directing the compounds to the in vivo target. The targeting ligands disclosed herein can serve to target expression-inhibiting oligomeric compounds, such as RNAi agents, to liver cells to modulate gene expression. The targeting ligands disclosed herein, when conjugated to a therapeutic compound, may be used in a variety of applications, including use in therapeutic, diagnostic, target validation, and genomic discovery applications. Compositions including the targeting ligands disclosed herein when linked to expression- inhibiting oligomeric compounds are capable of mediating expression of target nucleic acid sequences in liver cells, such as hepatocytes, which may be useful in the treatment of diseases or conditions that respond to inhibition of gene expression or activity in a cell, tissue, or organism.
Patent AU-2017369741-B2 (AU)
Title: Vehicle mirrors
Inventor: MILES SHANE ROBERT
IPC: B60R1/02
Filed: 2017-11-30
Granted: 2023-09-28
Abstract: A towing mirror including: a mount adapted to be mounted to a vehicle cabin; an extension component including a first member or portion extending from said mount and a second member operatively connected to said first member or portion for movement relative thereto from a retracted position to an extended position; and a mirror component operatively connected to said second member for pivoting movement relative thereto about a generally horizontal axis extending substantially in the intended direction of travel of the vehicle cabin to which the mirror is to be mounted.
Patent AU-2017375949-B2 (AU)
Title: Protein kinase inhibitors
Inventor: HE KAN
IPC: C07D413/10
Filed: 2017-12-12
Granted: 2021-09-09
Abstract: The present invention concerns novel deuterated and non-deuterated cyclic chemical compounds and their corresponding salts thereof active on protein kinases in general, and in particular as inhibitors of protein kinases. Additionally, methods of treating mammals with protein kinase-mediated diseases or conditions by administering a therapeutically effective amount of the novel deuterated or non-deuterated cyclic chemical compounds and their corresponding salts thereof.
Patent AU-2017424860-B2 (AU)
Title: Driving device, compressor, air conditioner, and driving method
Inventor: NIGO MASAHIRO
IPC: H02P25/18
Filed: 2017-07-25
Granted: 2020-10-22
Abstract: This drive device is equipped with an inverter for outputting voltage to a coil, a connection switching unit for switching the state of connection of the coil between a Y connection and a delta connection, and a control device. The control device stops inverter output when the coil connection state is the Y connection and the inverter current value reaches a first threshold A, or when the coil connection state is the delta connection and said current value reaches a second threshold B. The first threshold A and the second threshold B satisfy B<√3×A.
Patent AU-2018201905-B2 (AU)
Title: Improved Motor Vehicle Turbo Or Supercharger Diverter Valve System
Inventor: TURNER BRETT
IPC: F02B37/16
Filed: 2018-03-16
Granted: 2019-12-05
Abstract: The present invention provides a or super charged intake tract diverter valve system having a valve body 1 adapted to be sealingly mounted to said intake tract upstream of a throttle valve associated with said intake tract, said body 1 including a closure means 10 to operatively close off a diversion aperture 4.1 in said intake tract 3 so as to vent pressurised gases in said intake tract 3 to a bypass path or atmosphere at predetermined times, said system including an actuation means to allow said closure means 10 to open whereby pressurised gases in said intake tract will pass through said diversion aperture 4.1 into said bypass path or to atmosphere, characterised in that said closure means 10 includes a chamber 5.1 associated with said valve body 1 and a valve member 10 which cooperates with said chamber 5.1 to close said diversion aperture 4.1, said valve member 10 including at least one transfer aperture 12 through it, said valve member 10 being configured so that by means of said pressurised gases, said valve member has a net force provided from a surface area differential with respect to opposite sides of said valve member 10 so as to close said diversion aperture 4.1 or keep it closed, when gas pressure on opposite sides of said valve member is equal, and when a pressure differential is created so that an upstream side 10.1 of said valve member 10 has pressure greater than a downstream side 5.1, then said valve member 10 will move to open said diversion aperture, said system including said actuation means associated with said chamber 5.1 or said valve member 10, whereby when controlled to do so, said actuation means will open a control aperture 6 associated with said chamber 5.1 or said valve 10, to thereby create said pressure differential on the valve member 10 to thereby cause same to open said diversion aperture 4.1.
Patent AU-2018204331-B2 (AU)
Title: Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)
Inventor: WONG BRIAN
IPC: A61P19/02
Filed: 2018-06-18
Granted: 2020-03-12
Abstract: Methods of reducing cytokine levels and methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R) are provided. Such methods include, but are not limited to, methods of treating inflammatory conditions, such as rheumatoid arthritis. 10375519_1 (GHMatters) P99336.AU.1
Patent AU-2018225179-B2 (AU)
Title: Article with chassis having an elastic distribution, absorbent core and system and method for making same
Inventor: WRIGHT ANDREW
IPC: A61F13/49
Filed: 2018-02-22
Granted: 2022-02-03
Abstract: An absorbent article may include an inner elasticised chassis. An opening may be formed through the inner elasticised chassis. The absorbent article may include an outer elasticised chassis, and an absorbent member located between the inner elasticised chassis and the outer elasticised chassis. The inner elasticised chassis may include sets of elastic strands surrounding the absorbent member. The opening may be located in a space between the sets of elastic strands.
Patent AU-2018231170-B2 (AU)
Title: IL-15-based fusions to IL-12 and IL-18
Inventor: MARCUS WARREN D
IPC: C07K14/715
Filed: 2018-03-06
Granted: 2020-07-16
Abstract: The invention features multi-specific fusion protein complexes with one domain comprising IL-15 or a functional variant and a binding domain specific to IL-12 or IL-18.
Patent AU-2018255033-B2 (AU)
Title: Packaging material
Inventor: SEITO SHINYA
IPC: B65D65/40
Filed: 2018-04-19
Granted: 2020-09-10
Abstract: The purpose of the present invention is to provide, through simple means, a packaging material capable of exhibiting large amount of slip. Provided according to the present invention is a packaging material wherein a contact surface thereof which contacts viscous content is formed from a thermoplastic resin, the packaging material being characterized in that said contact surface has a mirror finish with a roughness Sa of 100 nm or less and a water contact angle (at 20°C) of 60 degrees or greater.
Patent AU-2018257536-B2 (AU)
Title: Pattern coated textile for active cooling
Inventor: MONDAL RAJIB
IPC: D06M23/16
Filed: 2018-03-09
Granted: 2020-07-30
Abstract: A pattern coated textile containing a textile having an upper surface and a lower surface and comprising a plurality of yarns, where at least a portion of the yarns comprise a synthetic polymer and a patterned coating on at least the lower surface. The patterned coating covers between about 5 and 95% of the surface area of the lower surface of the textile and contains a functioned polyester selected from the group consisting of an ethoxylated polyester, a sulfonated polyester, an ethoxylated and sulfonated polyester, and mixtures thereof. The patterned coating also contains a binder and an optional dye.
Patent AU-2018266248-B2 (AU)
Title: Homodetic cyclic peptides targeting a4β7 integrin
Inventor: VAZQUEZ MANUEL PEREZ
IPC: A61P37/06
Filed: 2018-05-10
Granted: 2022-01-27
Abstract: There is described herein antagonists of α4β7 integrin, and more particularly cyclic peptide antagonists, such as compounds of formula (I).
Patent AU-2018342475-B2 (AU)
Title: Fluid handling detectors
Inventor: GASSLER PAUL D
IPC: A61B5/00
Filed: 2018-09-28
Granted: 2021-07-01
Abstract: Described herein are devices for collecting and analyzing a fluid sample, the devices comprising a fluid-collecting porous material comprising at least one hydrophilic porous layer and one or more sensors adapted to provide a response to the presence of an analyte. The detectors are useful for collecting and analyzing a very small volume of sample and may include features that facilitate and direct flow of the sample through porous material.
Patent AU-2019202102-B2 (AU)
Title: Single line passive optical network converter module
Inventor: BROWN DAVID
IPC: H04B10/25
Filed: 2019-03-27
Granted: 2020-09-10
Abstract: A single line converter module comprises a housing; an environmentally hardened fiber optic 
connector located in the housing and configured to be optically coupled to a service terminal 
for receiving downstream optical frames; a single electrical connector located in the housing 
and coupled over a metallic medium to a network terminal providing a service to respective 
customer premise equipment (CPE); and an optical-to-electrical (O/E) converter located in 
the housing and configured to convert the downstream optical frames to an electrical signal 
for transmission over the metallic medium to the network terminal.  
23
Patent AU-2019202670-B2 (AU)
Title: Drug delivery devices with drug-permeable component and methods
Inventor: LEE HEEJIN
IPC: A61M31/00
Filed: 2019-04-16
Granted: 2020-04-02
Abstract: Implantable drug delivery devices include a housing having a closed drug reservoir lumen bounded by a first wall structure and a hydrophilic second wall structure, and a drug contained in the drug reservoir lumen, wherein the first wall structure is impermeable to the drug and the second wall structure is permeable to the drug. Methods of providing controlled release of drug to a patient include deploying a drug delivery device in the patient releasing a drug from the drug reservoir lumen via diffusion through the second wall structure. WO 2014/145638 PCT/US2014/030437 F IG. 8f'A 822 - 82 - -- -------- 808 FIG.---8B
Patent AU-2019246812-B2 (AU)
Title: Soft chewable pharmaceutical products
Inventor: ALTEHELD SUSI
IPC: A61K47/12
Filed: 2019-10-09
Granted: 2021-08-12
Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active 
ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a 
process for the manufacture of such soft chewable pharmaceutical product.
Patent AU-2019265796-B2 (AU)
Title: Flexible light guide and heat sink for endoscopic systems
Inventor: MCLEAN EDWARD
IPC: G02B23/24
Filed: 2019-05-09
Granted: 2022-11-03
Abstract: A flexible electronic light guide (18) for an endoscope (10) that acts as a heat sink for the light emitting diode (LED). A flexible tube (126) within the light guide extends from the LED to shunt heat away from the LED. The flexible tube may be a solid metal tube that is perforated to be flexible. The flexible tube may also be a braided wire jacket and may enclose a series of metal balls that are in contact with each other. The flexible tube may also be made of a plurality of different metals. The flexible tube may also be a hollow tube and support an air or liquid cooling system or be packed with metal balls that can be as small as grains of sand. The flexible tube may also be a linkage formed from a series of metal components held in tight contact by a spring.
Patent AU-2019268108-B2 (AU)
Title: Conduit connector for a patient breathing device
Inventor: GULLIVER LAURENCE
IPC: A61M16/00
Filed: 2019-11-20
Granted: 2022-03-03
Abstract: In an embodiment, a connector or connector assembly for attaching a nasal 
cannula with a gas delivery hose includes a sensor port for a sensor probe positioned 
near an end of a nasal cannula, which can allow the sensor probe to be placed closer 
to the patient's nostrils than previous connector parts allowed. In an embodiment, the 
connector is configured to advantageously allow the nasal cannula to rotate relative 
to the gas delivery hose, thereby allowing a patient or healthcare provider to untangle 
or otherwise straighten the hose or the cannula. In an embodiment, the connector 
assembly is configured to automatically align locking protrusions on a first component 
with locking recesses on a second component, where insertion of the second 
component within the first component causes the second component to rotate relative 
to the first component, thereby aligning the locking protrusions with associated locking 
recesses.  
-36-
1/37 
t:3 
N 
/ 
/ 
N / 
KS / 
SN il 
K, 
N 
I 
I 
N VNN 
1c~
Patent AU-2019309513-B2 (AU)
Title: Lens for eyewear and other headworn supports having improved optics
Inventor: ROBINSON DAVID
IPC: G02C7/02
Filed: 2019-07-26
Granted: 2022-11-17
Abstract: A lens is provided that has an improved optical configuration in order to provide enhanced off-axis optical performance by tending to reduce, eliminate, or minimize first order optical distortion. Embodiments may be used in non-corrective or corrective unitary or dual lens eyewear, for example in combination with a frame to support the lens in a path of a straight ahead line of sight forming a center axis of an eye of a typical wearer. The lens may comprise a lens body. The lens body may comprise a surface having a spheric, toric, cylindrical or freeform geometry and another surface having a freeform geometry. A lens thickness is defined between the surfaces. A prismatic power of the lens is improved, particularly for off-axis viewing angles.
Patent AU-2019440651-B2 (AU)
Title: Method for operating intelligent interactive tablet, and storage medium and related device
Inventor: WU RUIQIANG
IPC: G06F3/0483
Filed: 2019-11-28
Granted: 2023-07-06
Abstract: A method for operating an intelligent interactive tablet, and a storage medium and a related device, relating to the technical field of computers. The method comprises: displaying a playing mode interface of a slide document and an interface of an annotation application, wherein the interface of the annotation application is a transparent layer covering the interface of the slide document (S101); receiving a touch operation on the interface of the annotation application (S102); when the touch operation is a first type, performing page turning on the slide document (S103); and when the touch operation is a second type, performing annotation on the slide document on the interface of the annotation application (S104). Therefore, the method can effectively improve the convenience of slide operations after the annotation interface is called out.
Patent AU-2020201450-B2 (AU)
Title: Thiazolopyridine derivatives as GPR119 agonists
Inventor: PATIL RAKESH ISHWAR
IPC: A61P3/10
Filed: 2020-02-27
Granted: 2021-07-01
Abstract: The present invention relates to novel compounds of formula (I) as GPR119 agonist, 
compositions containing such compounds and methods of preparation thereof.  
X2X3 
R2 X, 
Formula (I) 
1002936737
Patent AU-2020202914-B2 (AU)
Title: Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
Inventor: JIN HAOLUN
IPC: C07D498/14
Filed: 2020-05-01
Granted: 2021-09-09
Abstract: Compounds for use in the treatment of human immunodeficiency virus 
(HIV) infection are disclosed. The compounds have the following Formula (I): 
O y1 y2 
W N N R1 
Z4 N O 
(I) 
including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1 , X, 
W, Yl, Y2 , Z1, and Z4 are as defined herein. Methods associated with preparation and 
use of such compounds, as well as pharmaceutical compositions comprising such 
compounds, are also disclosed.
Patent AU-2020203459-B2 (AU)
Title: Long-acting coagulation factors and methods of producing same
Inventor: FIMA UDI EYAL
IPC: C07K1/107
Filed: 2020-05-26
Granted: 2022-03-31
Abstract: Polypeptides comprising at least one carboxy- terminal peptide (CTP) of chorionic gonadotropin 
attached to the carboxy terminus but not to the amino terminus of a coagulation factor and 
polynucleotides encoding the same are disclosed. Pharmaceutical compositions and 
pharmaceutical formulations comprising the polypeptides and polynucleotides of the disclosure 
and methods of using and producing same are also disclosed.
Patent AU-2020239789-B2 (AU)
Title: Delivering variable positive airway pressure depending on awake state and sleep disordered breathing
Inventor: GERRED ANDREW GORDON
IPC: A61M16/00
Filed: 2020-09-25
Granted: 2023-06-22
Abstract: EDITORIAL NOTE 
APPLICATION NUMBER - 2020239789 
Please note: Abstract page 22 should be numbered 23.
- 22
ABSTRACT 
Positive airway pressure ("PAP") systems and methods are provided which supply 
a patient with a range of pressures for treatment when the patient is determined to be 
asleep, and an awake pressure for use when the patient is determined to be awake, the 
5 awake pressure configured for the comfort of the patient. The awake pressure is 
configured to be lower than the lower bound of the pressure range and can be a 
therapeutic or sub-therapeutic pressure. The PAP systems and methods disclosed herein 
advantageously allow for the pressure range to be tailored for effective treatment of sleep 
disordered breathing while allowing the awake pressure to be set for the comfort of the 
10 patient. This can advantageously increase both the efficacy of the treatment of SDB and 
patient compliance with the treatment.
Patent AU-2020244433-B2 (AU)
Title: Inoculants and methods for use thereof
Inventor: FRANCO CHRISTOPHER MILTON MATHEW
IPC: A01N63/00
Filed: 2020-09-29
Granted: 2023-04-06
Abstract: The present invention relates to methods for enhancing at least one growth 
parameter of a leguminous plant via co-inoculation of a leguminous plant with at 
5 least one rhizobial microorganism together with at least one actinobacterial 
microorganism. In further aspects, the present invention also relates to 
leguminous plants co-inoculated with at least one rhizobial microorganism 
together with at least one actinobacterial microorganism, as well as specific 
actinobacterial strains and inoculant compositions which are useful in 
10 accordance with the present invention.